T 1659/21 (Suspension formulation /BOEHRINGER) of 15.04.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T165921.20240415
- Date of decision
- 15 April 2024
- Case number
- T 1659/21
- Online on
- 10 July 2024
- Petition for review of
- -
- Application number
- 09757593.0
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- CAPSULE PHARMACEUTICAL DOSAGE FORM COMPRISING A SUSPENSION FORMULATION OF AN INDOLINONE DERIVATIVE
- Applicant name
- Boehringer Ingelheim International GmbH
- Opponent name
- Zentiva Group, a.s.
Teva Pharmaceutical Industries Ltd.
Generics (U.K.) Limited
Galenicum Health S.L.U. - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)
- Keywords
- Amendments - allowable (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution.